Emergence of Azole-Resistant Aspergillus fumigatus from Immunocompromised Hosts in India.

doi:10.1128/AAC.02264-17

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Emergence of Azole-Resistant Aspergillus fumigatus from Immunocompromised Hosts in India.

Antimicrobial agents and chemotherapy - 1 Aug 2018

Dabas Yubhisha, Xess Immaculata, Bakshi Sameer, Mahapatra Manoranjan, Seth Rachna

Abstract excerpt

This prospective study shows that the rate of azole-resistant Aspergillus fumigatus (ARAF) in an immunocompromised Indian patient population with invasive aspergillosis (IA) is low, 6/706 (0.8%). This low rate supports the continued use of voriconazole as the first line of treatment. However, the ARAF isolates from India in this study exhibited three kinds of unreported cyp51A mutations, of which two were at hot...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aspergillus fumigatus
Share to Azoles
Share to Drug Resistance, Fungal
Share to Fungal Proteins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunocompromised Host

Share to India

Share to Microbial Sensitivity Tests

Share to Voriconazole

Source

Open in PubMed Open full text

Identifiers

PMID: 29891597
DOI: 10.1128/AAC.02264-17
PMCID: PMC6105863

Genes

ARAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.